Viemed Healthcare, Inc.
NCM: VMDLive Quote
📈 ZcoreAI Score
Our AI model analyzes Viemed Healthcare, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get VMD Z-Score →About Viemed Healthcare, Inc.
Healthcare
Medical Devices
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
📊 Fundamental Analysis
Viemed Healthcare, Inc. demonstrates a profit margin of 5.5%, which is below the sector average, suggesting competitive pressure.
The company recently reported 25.5% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is 11.1%, which suggests room for improvement in capital utilization.
At a current price of $9.51, VMD currently trades near the top of its 52-week range (87%) (Range: $5.93 - $10.06).
💰 Valuation Insight
VMD is valued broadly in line with the sector at a PE of 25.70. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$367.11M
Trailing P/E
25.70
Forward P/E
23.77
Beta (5Y)
1.16
52W High
$10.06
52W Low
$5.93
Avg Volume
270K
Day High
Day Low